SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation
Related Posts
Scapin G, Cillis JL, Goulard MC, Patch TC, Gomez Limia CE, Ding Y, Du W, Dharampuriya PR, Hagedorn EJ, Anderson H, Musso GA, Curley CR,[...]
Li YR, Liu Z, Zhu E. Biomaterials mimicking immunological synapses for enhanced T cell activation in CAR-T therapy. Sci Bull (Beijing). 2025 Apr 21:S2095-9273(25)00399-8. doi:[...]
Emeruwa UN, Çapi A, Jacobs MB, Laurent LC, Bello NA, Gyamfi-Bannerman C. Incidence and Risk Factors of De Novo Postpartum Hypertension: Understanding Links to Long-Term[...]